Results 91 to 100 of about 178,635,816 (158)

Carcinosarcoma of the Esophagogastric Junction

, 2008
Carcinosarcoma of the esophagus and the stomach are rare neoplasms characterized by the simultaneous presence of carcinomatous and sarcomatous elements. There is no report in the literature of carcinosarcoma of the esophagogastric junction. We present a
Marcello Dei Poli, Enrico Ruffini, Eleonora Raggio, Michele Camandona, Dino Solerio, Isabella Castellano   +5 more
core   +1 more source

Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study

Background: Optimal multimodal treatment for esophagogastric junction adenocarcinoma remains debated. While the ESOPEC trial supports perioperative FLOT, real-world evidence is limited, particularly for Siewert type II tumors.
Atci, Muhammed Mustafa, Mermit Ercek, Berrak, Erciyestepe, Mert, Gurdal, Necla, Akyel, Resit, Aydin, Okan, Ürün, Muslih, BİLİCİ, Mehmet, Gunenc, Senar, Celik, Emir, Erturk, Kayhan, Sucuoglu Isleyen, Zehra, Gurbuz, Halide Sena, Sakin, Abdullah, Dinc Sonusen, Sermin   +14 more
core   +1 more source

Integrated single-cell RNA sequencing reveals the tumor heterogeneity and microenvironment landscape during liver metastasis in adenocarcinoma of esophagogastric junction

Frontiers in Immunology
BackgroundAdenocarcinoma of the esophagogastric junction (AEGJ) is a highly aggressive tumor that frequently metastasizes to the liver. Understanding the cellular and molecular mechanisms that drive this process is essential for developing effective ...
Junrui Xu, Ussama Sadiq, Wangruizhi Zhao, Hengbo Xia, Yiwei Liu, Renquan Zhang, Aman Xu   +6 more
doaj   +1 more source

Immunotherapy as a new perspective for the therapy of esophageal cancer

Innovative Surgical Sciences
The therapeutic landscape in nearly every therapeutic line in advanced/metastatic patients with squamous cell carcinoma (SCC) and esophagogastric adenocarcinoma (EGC) is enriched by recent approvals of immune checkpoint inhibitors (ICIs).
Huber Yvonne, Moehler Markus, Högner Anica   +2 more
doaj   +1 more source

Marital Status Is a Prognostic Factor for Cardiovascular Mortality but Not a Prognostic Factor for Cancer Mortality in Siewert Type II Adenocarcinoma of the Esophagogastric Junction. [PDF]

Gastroenterology Res, 2023
Zheng ZQ, Sun XZ.
europepmc   +1 more source

Years of Life Lost of Patients With Early Adenocarcinoma of the Esophagogastric Junction Compared to Esophageal or Gastric Adenocarcinoma. A Registry-Based Study. [PDF]

Cancer Med
Bollschweiler E, Hölscher AH, Schumacher B, Pech O, Drebber U, in Cooperation with the German Cancer Registry, RKI.   +6 more
europepmc   +1 more source

Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry. [PDF]

Transl Oncol, 2023
Lai Z, Bai Z, Yang S, Zhang R, Xi Y, Xu J.   +5 more
europepmc   +1 more source

Robot-assisted Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a cohort study of 156 cases. [PDF]

Ann Med Surg (Lond)
Duan X, Wang H, Zhang Y, Yue J, Chen C, Ma Z, Chen Z, Zhang C, Wang S, Hou C, Zhang W, Jiang H.   +11 more
europepmc   +1 more source

Two Cases of Laparoscopic Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction Using a Transhiatal Approach and Complicated by Hemopericardium. [PDF]

Am J Case Rep, 2023
Wang N, Ma L, Gao Z, Liu S, Qin X, Ren M, Bai D, Peng Y, Tian Y.   +8 more
europepmc   +1 more source

Targeting DOT1L Reactivates HERV-K to Drive Cell-Autonomous and Paracrine Senescence in Adenocarcinoma of the Esophagogastric Junction. [PDF]

Cancer Res
Feng H, Ling F, Xi Z, Li R, Lv X, Guo J, Su L, Zhou J, Zheng J, Xing F, Li Y.   +10 more
europepmc   +1 more source